Related Experiment Video
Updated: Nov 1, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Pathophysiology of severe primary graft dysfunction in orthotopic heart transplantation
Hoong Sern Lim1, Aaron Ranasinghe1, David Quinn1
1Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Insights
Primary graft dysfunction (PGD) in heart transplantation involves right heart failure with reduced capacitance and impaired contractility. Recovery shows improvement but not full normalization, allowing successful mechanical circulatory support weaning.
Area of Science:
- Cardiovascular Physiology
- Transplantation Medicine
- Graft Dysfunction Pathophysiology
Background:
- Donor heart insults lead to primary graft dysfunction (PGD) after heart transplantation.
- PGD presents with significant pathophysiological changes impacting graft function.
- Understanding PGD pathophysiology is crucial for improving patient outcomes.
Purpose of the Study:
- To model and describe the pathophysiology of severe primary graft dysfunction (PGD).
- To analyze the evolution of PGD pathophysiology during the recovery phase.
- To utilize an established cardiovascular model for detailed hemodynamic analysis.
Main Methods:
- Hemodynamic data from 20 severe PGD patients (requiring mechanical circulatory support, MCS) and 20 non-PGD patients were analyzed.
- Data collected at baseline (T0), 6 hours (T6), and recovery (MCS explant).
- A cardiovascular model by Burkhoff and Dickstein was employed for pathophysiology modeling.
Main Results:
- Severe PGD demonstrated a rightward shift in diastolic pressure-volume relationship, indicating reduced chamber capacitance.
- Elevated right ventricular end-systolic elastance (RV Ees) and reduced preload-recruitable stroke work (PRSW) were observed in severe PGD.
- Recovery from MCS showed improved RV Ees, capacitance, and PRSW, though remaining lower than in non-PGD patients.
Conclusions:
- Severe PGD is characterized by a right heart failure phenotype with reduced chamber capacitance, increased stiffness, and impaired contractility.
- Complete normalization of parameters is not necessary for successful weaning from mechanical circulatory support.
- The study provides insights into the dynamic changes in PGD pathophysiology during recovery.
Background:
A series of insults on the donor heart result in pathophysiological changes that manifest as primary graft dysfunction (PGD) post-orthotopic heart transplantation. The objectives of this study were: (i) describe the pathophysiology of severe PGD using an established cardiovascular model; and (ii) the evolution of the pathophysiology during recovery from severe PGD.
Methods:
Hemodynamic data from 20 consecutive patients with severe PGD (need for mechanical circulatory support, MCS) at baseline (T0), 6 h (T6) and "recovery" (explant of support), and 20 consecutive patients without severe PGD were used to model the pathophysiology using the cardiovascular model described by Burkhoff and Dickstein.
Results:
There was a progressive (from T0 to T6) up- and leftward shift in the diastolic pressure-volume relationship, especially of the right ventricle (RV), resulting in reduced capacitance. RV end-systolic elastance (Ees) was significantly elevated in severe PGD but preload-recruitable stroke work (PRSW) was significantly lower compared to patients without severe PGD. "Recovery" (after liberation from MCS) was associated with improvement in RV Ees, chamber capacitance and PRSW, although they remained significantly lower than patients without severe PGD.
Conclusion:
Severe PGD of the dominant right heart failure phenotype is characterized by reduced chamber capacitance, increased "stiffness" and impaired contractility. Complete normalization was not required for successful weaning of MCS.
More Related Videos
12:40A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
09:25An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pathophysiology of Heart Failure